Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 while preserving its beneficial non-catalytic functions. Augustine’s lead program, AGT-100216, is the first selective HDAC6 inhibitor for long-term treatment of Charcot-Marie-Tooth (CMT) disease. With its novel non-hydroxamate, non-hydrazide producing chemotype, Augustine’s HDAC6 approach is selective, avoids the limitations of other chemotypes, and built for chronic diseases. With this novel approach, the Company will also be targeting diseases beyond CMT, including neurodegenerative and cardio-metabolic diseases. Augustine Therapeutics was founded on the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven in Belgium.
——— *Disclaimer* ———
We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.
Company Details
- Employees
- 24
- Founded
- -
- Address
- Gaston Geenslaan 1, Leuven,flemish Region 3001,belgium
- co****@****etx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- augustinetx.com
- Keywords
- in peripheral neuropathy..
- HQ
- Leuven, Flemish Region
Augustine Therapeutics Questions
Augustine Therapeutics's website is augustinetx.com
Augustine Therapeutics's LinkedIn profile is https://be.linkedin.com/company/augustine-therapeutics
Augustine Therapeutics has
24 employees.
View email and phone details for 24
employees at Augustine Therapeutics.
Augustine Therapeutics's industry is
Biotechnology Research
Augustine Therapeutics's top competitors are
Tempero Bio,
Flamingo Therapeutics,
Asabys Partners,
Confo Therapeutics,
Rewind Therapeutics,
Hillstar Bio,
Montis Biosciences,
Character Biosciences,
Agomab,
Averna Therapeutics.
Augustine Therapeutics's support email address is contact@augustinetx.com
Augustine Therapeutics's categories are Biotechnology Research
Augustine Therapeutics's founding year is 2019
